Clinical Trial Update: The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for MGA031 (Protégé Study) in recent-onset type 1 diabetes mellitus across Phase 2 and Phase 3 has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• MGA031

Snippet

Sponsor: MacroGenics | Conditions: Type 1 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-12-05